Prosecution Insights
Last updated: August 15, 2026
Application No. 17/281,239

Monovalent Selective Cation Exchange Membrane

Non-Final OA §103§112
Filed
Sep 27, 2021
Priority
Sep 25, 2018 — provisional 62/736,176 +3 more
Examiner
ROLLAND, ALEX A
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Evoqua Water Technologies LLC
OA Round
3 (Non-Final)
47%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
74%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
287 granted / 605 resolved
-17.6% vs TC avg
Strong +26% interview lift
Without
With
+26.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
30 currently pending
Career history
645
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
65.5%
+25.5% vs TC avg
§102
11.8%
-28.2% vs TC avg
§112
20.8%
-19.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 605 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 3/31/26 has been entered. Election/Restrictions Claims 9-30 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 4/25/25. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim 36 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. There is no support in the specification for a surface charge that is opposite from bulk fixed charges of the cross-linked ion-transferring polymeric layer. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 31 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 31 is vague and indefinite for a) lacking antecedent basis for “the positively charged functionalizing layer and b) improper Markush group using the word “comprises”. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-8, 31-36 is/are rejected under 35 U.S.C. 103 as being unpatentable over WO 2011025867 to Lin in view of US 5389449 to Afeyan. Claims 1-4, 6-8, 31: Lin teaches a method for manufacturing an ion exchange membrane that forms a cross-linked ion-transferring polymeric layer on a surface of a polymeric microporous substrate. The process includes the polymeric microporous substrate (pg. 9) coated with a solution of charged monomer (i.e., iongenic monomer), multifunctional monomer, and polymerization initiator and polymerized/crosslinked by heat or UV (pg. 13). Lin does not teach adsorbing a further chlorosulfonated methacrylate group to this cross-lined ion-transferring polymeric layer or the subsequent aminating and functionalization. However, Afeyan teaches the surface modification of ion exchange membranes (abstract). The process applies a halosulfonating agent onto the substrate (4:61-65), such as a chlorosulfonating agent (4:66-68), aminating the chlorosulfonated surface by applying PEI (5:50-63), and functionalizing the amine groups in the PEI (i.e., quaternized; positively charged) (6:10-13). Afeyan does not teach the chlorosulfonating agent includes a methacrylate group, although is open to any agent that can react with various substrate to produce chlorosulfone groups on the substrate surface (5:42-48). Turning back to Lin, the main monomer used by Lin is 2-SEM. By comparison, the claimed chlorosulfonated methacrylate compound is 2-methacryloyloxy ethylsulfonyl. PNG media_image1.png 314 548 media_image1.png Greyscale PNG media_image2.png 334 406 media_image2.png Greyscale These compositions are the same except for the substitution of and -OH group for a -Cl group. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to practice the method of Lin followed by the method of Afeyan to produce a functionalized ion exchange membrane. It further would have been obvious to use the chlorinated 2-SEM as the chlorosulfonating agent in order to maintain compositional consistency across the membrane structure, better incorporate it into the cross-linked ion-transferring polymeric layer, and avoids the problem of forming undesirable sulfonic acid groups (5:11-32). Claim 5: Afeyan teaches PEI with a MW from 600-1000000 Da (5:59). Claims 32-33: As these are properties of the resulting membrane, they are inherent as stemming from an identical method of manufacture. Claims 34-35: Membrane is 55-155 microns thick (pg. 12). Claim 36: Surface charge and bulk charge are different (pg. 1). Response to Arguments Applicant's arguments filed 3/31/26 have been fully considered but they are not persuasive. Afeyan teaches aminating with PEI. This is going to result in “a surface intermediate layer comprising a chemically immobilized amine containing group”. Thereafter, the amine groups are quaternized or derivatized which is “reacting the surface intermediate layer with a charged functionalizing layer” in the context of this invention. For example, functionalizing to form the charged functionalizing layer includes binding a charged functionalizing group to the chemically immobilized amine layer (Applicant’s spec., pg. 22 and 34). This interpretation of functionalization is precisely what Afeyan teaches. Regarding claim 36, this claim appears to be relying on support from [0057] of the PGPUB. However, this subject matter is also taught by Lin, pg. 1. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEX A ROLLAND whose telephone number is (571)270-5355. The examiner can normally be reached M-F 10-6:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached at 5712721234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEX A ROLLAND/Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

Sep 27, 2021
Application Filed
Sep 21, 2021
Response after Non-Final Action
May 19, 2025
Non-Final Rejection mailed — §103, §112
Aug 19, 2025
Response Filed
Oct 23, 2025
Final Rejection mailed — §103, §112
Mar 31, 2026
Request for Continued Examination
Apr 03, 2026
Response after Non-Final Action
Jun 02, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12692432
QUANTUM DOT SURFACE TREATMENT METHOD AND SURFACE TREATMENT APPARATUS
3y 2m to grant Granted Jul 28, 2026
Patent 12686917
METHODS FOR DEPOSITING A FILM ON A SURFACE OF A SUBSTRATE BY CYCLICAL DEPOSITION METHODS INCLUDING PULSED PURGE PROCESSES
2y 1m to grant Granted Jul 21, 2026
Patent 12616996
METHODS FOR COATING SUBSTRATES
3y 1m to grant Granted May 05, 2026
Patent 12613366
ARTICLE INCLUDING A STACK OF ALTERNATING LAYERS
6y 0m to grant Granted Apr 28, 2026
Patent 12612522
NANOPARTICLE HYDROGELS
2y 2m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
47%
Grant Probability
74%
With Interview (+26.4%)
3y 9m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 605 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month